Drug Channels

JUNE 12, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. Our indisputable math exposes the little-understood economics behind specialty pharmacies in the 340B program.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

OCTOBER 2, 2024

Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. Fein, Ph.D., All rights reserved.

Hospitals 52

Hospitals Specialty Pharmacies Drug Pricing 52

Drug Channels

NOVEMBER 9, 2022

Fein will share his latest thinking on a wide range of topics, including: Retail and specialty pharmacy trends Vertical integration and consolidation The Inflation Reduction Act of 2022 The Medicare Part D Redesign Biosimilars Discount cards and cash-pay pharmacies The growing impact of hospitals and health systems The 340B Drug Pricing Program Federal (..)

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 98

Proxsys Rx

OCTOBER 25, 2024

For more information on any aspect of developing & managing a successful 340B program AND/OR retail and specialty pharmacies, contact: HOWARD HALL C: 214.808.2700 | howard.hall@proxsysrx.com FULL POST According to a graphic published on its website, in 2023 Johnson & Johnson provided $42.8

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing 52

Drug Channels

NOVEMBER 23, 2021

In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon P.S. You can also find my daily posts on LinkedIn , where I have more than 21,000 followers. to 1:30 p.m.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Biosimilars Hospitals 40

Proxsys Rx

MAY 1, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. 340B revenues for numerous covered entities has plummeted.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Proxsys Rx

APRIL 10, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. 340B revenues for numerous covered entities has plummeted.

Drug Pricing 52

Drug Pricing Hospitals Specialty Pharmacies 52

Proxsys Rx

DECEMBER 11, 2023

Nowhere have those restrictions been more punitive — and, often, unwarranted — than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Labelling 52

Drug Channels

MARCH 15, 2022

Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

FEBRUARY 23, 2021

Let’s melt away this foul February with our monthly selection of scorching news from around the drug channel. In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar!

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Independent Pharmacies Online Pharmacies 52

Proxsys Rx

MARCH 1, 2024

Nowhere have those restrictions been more punitive — and, often, unwarranted — than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 40

Specialty Pharmacies Hospitals Drug Pricing Labelling 40

Proxsys Rx

APRIL 19, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. A single hospital can easily have five TPAs and 70 contract pharmacies. The Supreme Court voted unanimously to reverse 340B cuts.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Hospitals 40

Proxsys Rx

JANUARY 12, 2024

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to $435 million in savings generated for the hospitals and health systems we serve. A single hospital can easily have five TPAs and 70 contract pharmacies. The Supreme Court voted unanimously to reverse 340B cuts.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). Pharmacy benefit managers: transparency, accountability, and impact on patient care. Casalino, L.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

HealthPartners

JULY 21, 2021

In their view, just as you wouldn’t separate drug therapies from medical care, pharmacy and medical benefits should be tightly integrated too. HealthPartners is a health solutions company providing care through hospitals and clinics, as well as insurance coverage for companies. And we agree.

Biosimilars 52

Biosimilars Specialty Pharmacies Mail-Order Pharmacies Health Insurance Companies 52

Putting Patients First Blog

JANUARY 27, 2025

Timely implementation is particularly critical for beneficiaries requiring immediate mental health or substance use treatment, where delays can lead to worsening health outcomes, increased hospitalization rates, and preventable mortality. Issue Brief: Improving Prescription Drug Price and Cost Transparency. 2024.30.2.206.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharma Marketing Network

JUNE 8, 2020

I started my career in consulting implementing systems inside of a couple dozen different hospitals and then I went on to find Microsoft’s healthcare partner ecosystem. Even there, that’s impacted by some distortions around pbms and how hospitals radically markup those drugs, but that’s probably the one exception.

Health and Personal Care Stores 40

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies 40